Back
Freeport-McMoRan, Inc. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Buy
74
FCX
Freeport-McMoRan, Inc.
Last Price:
$48.08
Seasonality Move:
7.92%
Sell
32
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.71
Seasonality Move:
-18.07%
Buy
74
Freeport-McMoRan, Inc. (FCX)
is a Buy
Is Freeport-McMoRan, Inc. a Buy, Sell or Hold?
-
The current Freeport-McMoRan, Inc. [FCX] share price is $47.82. The Score for FCX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
FCX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.71. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FCX Stock Price Chart
What is Freeport-McMoRan, Inc.'s stock price today?
-
The Freeport-McMoRan, Inc. share price today is $47.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight buying pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
FCX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.75 | Buy |
| Relative Strength Index (14 RSI): | 70.75 | Buy |
| Chaikin Money Flow: | 538379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.48 - 46.26) | Buy |
| Bollinger Bands (100): | (39.7 - 44.96) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 45.61 | Sell |
| Chaikin Money Flow: | -20975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.65) | Sell |
| Bollinger Bands (100): | (12.3 - 15.28) | Sell |
FCX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.83 | Buy |
| 20-day SMA: | 44.14 | Buy |
| 50-day SMA: | 42.33 | Buy |
| 200-day SMA: | 40.93 | Buy |
| 8-day EMA: | 46.79 | Buy |
| 20-day EMA: | 44.88 | Buy |
| 50-day EMA: | 43.17 | Buy |
| 200-day EMA: | 41.94 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.32 | Sell |
| 20-day SMA: | 11.56 | Buy |
| 50-day SMA: | 12.92 | Sell |
| 200-day SMA: | 11.86 | Sell |
| 8-day EMA: | 12.05 | Sell |
| 20-day EMA: | 12.05 | Sell |
| 50-day EMA: | 12.68 | Sell |
| 200-day EMA: | 12.23 | Sell |
Freeport-McMoRan, Inc. Earnings Growth & FCX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.73 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Freeport-McMoRan, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||